More News

21 Jan 2020 PhoreMost enters multi-project drug discovery collaboration with Otsuka Pharmaceutical
17 Jan 2020 Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
17 Jan 2020 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
16 Jan 2020 Fibrocor and Galapagos sign expanded collaboration in fibrosis
15 Jan 2020 Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products
15 Jan 2020 Dermavant Enters into Exclusive License Agreement with JT for Development and Commercialization of Tapinarof in Japan
14 Jan 2020 Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
14 Jan 2020 Allele and Astellas Enter into an Expanded License for the Development of iPSC Lines
13 Jan 2020 Editas Medicine and Sandhill Therapeutics, Inc. Announce Collaboration to Develop Engineered Cell Medicines to Treat Cancer
13 Jan 2020 Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)
13 Jan 2020 Fauna Bio and Novo Nordisk enter into Research Collaboration to Discover Novel Therapeutics for Obesity
13 Jan 2020 Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
13 Jan 2020 Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
13 Jan 2020 CNS Pharmaceuticals Licenses Breakthrough Technology from MD Anderson, Doubling its Drug Pipeline
13 Jan 2020 Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates
13 Jan 2020 Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog
13 Jan 2020 Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
13 Jan 2020 Bayer and Daré Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene®
13 Jan 2020 Biogen to Acquire Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease from Pfizer Inc.
13 Jan 2020 MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab (news with additional features)
12 Jan 2020 Serimmune and Atreca, Inc. Establish Research Collaboration Agreement in Oncology
12 Jan 2020 Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases
12 Jan 2020 Amunix Pharmaceuticals Announces Technology Licensing Agreement with Roche to Advance Novel Therapeutics Outside Oncology
12 Jan 2020 Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skin
11 Jan 2020 Lilly Announces Agreement to Acquire Dermira

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top